North America Latent Tuberculosis Infection Screening Test Market was valued at USD 0.15 Billion in 2022 and is projected to reach USD 0.25 Billion by 2030, growing at a CAGR of 7.5% from 2024 to 2030.
Latent tuberculosis (TB) is a critical health condition that affects millions of individuals North Americaly, with a significant burden in North America. The importance of early detection and intervention cannot be overstated, as it prevents the progression of latent TB into active TB, which is highly contagious and often fatal. Screening for latent tuberculosis infection (LTBI) has therefore become essential, particularly in high-risk populations like healthcare workers, immigrants, and individuals with compromised immune systems. The demand for reliable and accurate LTBI screening tests is rapidly increasing in North America, where health agencies and industries are prioritizing early diagnosis and treatment to curb the spread of TB.
The rise in TB cases and heightened awareness around TB prevention has led to a surge in the demand for screening tests. Industries such as healthcare, pharmaceuticals, and research institutions are key drivers of this growth. These industries require LTBI screening tests to ensure the safety and health of their workers, as well as to develop new treatment solutions and TB management strategies. For example, healthcare workers are regularly screened due to their direct exposure to patients with TB, making these tests indispensable in maintaining public health safety.
Additionally, regulatory authorities in North America are increasingly mandating LTBI testing, especially in high-risk areas. Government health departments have implemented guidelines that encourage routine screenings among individuals who may have been exposed to TB or exhibit early symptoms. This requirement has led to a booming market for screening tools, with diagnostic companies offering innovative solutions that streamline testing procedures and provide faster results.
Furthermore, industries involved in research and development of TB medications and vaccines are investing heavily in screening technologies. Accurate diagnosis of latent TB allows for better monitoring of treatment efficacy, ultimately accelerating the development of new treatments and vaccines.
Given the increasing demand for LTBI screening, the North America Latent Tuberculosis Infection Screening Test Market is expected to see continued growth, driven by the need for early detection, improved healthcare standards, and advanced testing technologies.
Get an In-Depth Research Analysis of the North America Latent Tuberculosis Infection Screening Test Market Size And Forecast [2025-2032]
Qiagen
Oxford Immunotec
Bio-Rad Laboratories
Thermo Fisher Scientific
Sanofi
Par Sterile
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the North America Latent Tuberculosis Infection Screening Test Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the North America Latent Tuberculosis Infection Screening Test Market
Hospital
Diagnostic Laboratories
Others
Based on Types the Market is categorized into Below types that held the largest Latent Tuberculosis Infection Screening Test market share In 2023.
Tuberculin Skin Test (TST)
Interferon Gamma Released Assay (IGRA)
North America (United States, North America and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Latent Tuberculosis Infection Screening Test Market Research Analysis
1. Introduction of the North America Latent Tuberculosis Infection Screening Test Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. North America Latent Tuberculosis Infection Screening Test Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. North America Latent Tuberculosis Infection Screening Test Market, By Type
6. North America Latent Tuberculosis Infection Screening Test Market, By Application
7. North America Latent Tuberculosis Infection Screening Test Market, By Geography
North America
Europe
Asia Pacific
Rest of the World
8. North America Latent Tuberculosis Infection Screening Test Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading North America Research and Consulting firm servicing over 5000+ North America clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/